← FDA Drug Approvals (Drugs@FDA)

GABAPENTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM · Approved 2010-12-17

Drug application

FDA Application #
ANDA090858
Application type
Abbreviated New Drug Application (Generic)
Brand name
GABAPENTIN
Generic name
GABAPENTIN
Active ingredients
GABAPENTIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
ALKEM
Manufacturer
Ascend Laboratories, LLC
First approval
2010-12-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown